Share on StockTwits
 

Quintiles Transnational Holdings (NYSE:Q) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a report issued on Monday, Stock Ratings Network.com reports. The firm currently has a $55.20 price target on the stock. Zacks‘ price objective suggests a potential upside of 3.86% from the stock’s previous close.

Quintiles Transnational Holdings (NYSE:Q) traded up 1.82% during mid-day trading on Monday, hitting $53.15. 1,282,106 shares of the company’s stock traded hands. Quintiles Transnational Holdings has a 1-year low of $40.10 and a 1-year high of $53.17. The stock has a 50-day moving average of $47.97 and a 200-day moving average of $44.96. The company has a market cap of $6.891 billion and a price-to-earnings ratio of 29.49.

Quintiles Transnational Holdings (NYSE:Q) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.58 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.55 by $0.03. The company had revenue of $1.38 million for the quarter, compared to the consensus estimate of $980.64 million. The company’s quarterly revenue was up 6.1% on a year-over-year basis. Analysts expect that Quintiles Transnational Holdings will post $2.41 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on Q. Analysts at Bank of America reiterated a “buy” rating on shares of Quintiles Transnational Holdings in a research note on Friday. They now have a $60.00 price target on the stock, up previously from $55.00. Separately, analysts at Robert W. Baird raised their price target on shares of Quintiles Transnational Holdings from $55.00 to $56.00 in a research note on Monday, February 3rd. Finally, analysts at Goldman Sachs upgraded shares of Quintiles Transnational Holdings from a “neutral” rating to a “buy” rating in a research note on Tuesday, January 21st. They now have a $58.00 price target on the stock, up previously from $50.00. One analyst has rated the stock with a sell rating, four have assigned a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $51.08.

Quintiles Transnational Holdings Inc is a provider of biopharmaceutical development services and commercial outsourcing services.

To view Zacks’ full report, visit www.zacks.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.